Flap endonucleases (FENs) play key roles in cells in all domains of life by acting in lagging strand DNA replication and long-patch base excision repair (LP-BER). Both processes generate 5′-single stranded (ss) DNA or RNA in bifurcated structures known as 5′-flaps. FEN1 removes 5′-flaps without regard to sequence using its divalent metal ion-dependent phosphodiesterase activity (
Tomlinson et al., 2010). Consistent with its crucial role in DNA replication, human FEN1 is highly expressed in all proliferative tissues. Yet, many cancers show even higher levels of FEN1 expression, in several cases correlated with tumor aggressiveness (
Finger and Shen, 2010). Thus, FEN1 specific inhibitors have chemotherapeutic potential (
Tumey et al., 2005). Although FEN1 deletion (FEN1
-/-) is embryonically lethal in mice (
Larsen et al., 2003), insights into its biology come from yeast
FEN1 nulls (
Reagan et al., 1995), which are viable but have mutator phenotypes indicating severe genomic instability (
Liu et al., 2004;
Navarro et al., 2007). Homozygous
FEN1 null DT40 chicken cells are viable but sensitive to oxidative DNA damaging agents (
Matsuzaki et al., 2002), consistent with FEN1's role in LP-BER. FEN1 is also implicated in mitochondrial genome maintenance (
Kalifa et al., 2009). Furthermore, mutations that decrease expression levels or alter FEN1 biochemical properties predispose humans and mice to cancers (
Finger and Shen, 2010).
FEN1 efficiency and specificity is critical as human DNA replication generates ~50 million Okazaki primers each cell cycle. Failure to precisely remove these primers creates gaps or overlaps that would prevent efficient ligation, delay cell division and initiate post-replicative repair mechanisms, endangering genomic fidelity (
Debrauwere et al., 2001). FENs possess multiple nucleic acid hydrolytic activities
in vitro including cleavage of double flaps (5′- and 3′-flaps) that mimic equilibrating replication intermediates (
Lyamichev et al., 1999), nicked DNA with no 5′-flap both with and without a 3′-flap, and structures where the 5′-flap can form a fold back hairpin or gapped flaps (
Finger et al., 2009). Other FEN1 activities may reduce repeat expansions (
Singh et al., 2007). The cellular substrate for PCNA-scaffolded FEN1 action is an equilibrating double flap with a short 5′-ss DNA flap. Critical to replication efficiency, the FEN1 product from a double flap can be ligated without further processing (
Liu et al., 2004). Although RNA and DNA phosphodiester bonds are exceptionally stable to attack by water or hydroxide (
Schroeder et al., 2006), FEN1s enhance the hydrolysis rate of targeted phosphodiester bonds ~10
17 fold. Indeed, the catalytic efficiency of FEN1 on its optimal substrate approaches enzyme:substrate association rates in solution (
Finger et al., 2009). Thus, FEN1:DNA reactions may be diffusion controlled, as seen for other charged interactions like plastocyanin with cytochrome c (
Roberts et al., 1991). Yet, the basis of FEN1's specificity and catalytic power are unknown.
FEN1:DNA recognition models generally focus on the 5′-ssDNA flap portion of the substrate, but whether the FEN1 threads the free end through the helical arch or the arch clamps the 5′-flap ssDNA without threading is debated (
Chapados et al., 2004;
Devos et al., 2007;
Liu et al., 2004). After initial interaction with the free 5′ terminus, both models propose that FEN1 slides or tracks down the ssDNA to the ss-dsDNA junction whereupon incision occurs. Functional data involving modifications to the 5′-flap both support and contradict the tracking hypothesis showing that bulky alterations of the 5′-flap are in some cases tolerated but in others drastically retard reaction (
Finger et al., 2009).
Paradoxically, the diverse specificity of sequence-related enzymes in the 5′ nuclease superfamily for substrates without 5′-ss termini does not fit the ssDNA-based mechanisms. EXOI, XPG, and GEN1, whose activities span multiple DNA repair pathways, are members of the 5′ nuclease superfamily with FEN1 (
Lieber, 1997;
Tomlinson et al., 2010). However, XPG and GEN1 cleave DNA bubbles and four-way junctions, respectively: substrates with ss-dsDNA junctions but lacking 5′-termini for threading (
Ip et al., 2008;
O'Donovan et al., 1994). So a general model that explains FEN1 specificity for 5′-ss termini (whether ssDNA or a 5′-gapped flap) while reconciling substrate diversity of the 5′ nuclease superfamily is lacking.
To help elucidate the molecular basis for FEN1 functions and resolve paradoxes regarding 5′ nuclease superfamily specificities, we solved three crystal structures of human FEN1 with DNA, allowing comparative analyses of complexes with substrate and product DNA. Coupled with mutational and biochemical analyses, these FEN1:DNA complex structures reveal an unexpected sophistication to the recognition mechanism. Two separate DNA binding sites located ~1 dsDNA turn apart impose severe substrate bending, a feature likely to be superfamily conserved. These DNA binding sites coupled to helical wedges require that the 5′-flap DNA, located adjacent to the DNA bend, enter through a gateway formed between two superfamily-conserved α-helices. Substantial conformational changes in the FEN1 regions that bind the 3′- and 5′-DNA flaps enforce structure-specific binding. The combined enzyme-DNA structures show that in the reactive conformation of a FEN1 substrate, three nucleotides (nts) of the double flap DNA are unpaired, one at the 3′-terminus and two flanking the scissile phosphodiester. The collective results support a mechanism for FEN1 that resolves apparently contradictory biochemical data regarding the 5′-ssDNA terminus, explains FEN1 substrate specificity, and accommodates the diverse biological specificities of the 5′-nuclease superfamily.